This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
Mark Your Calendar for This Year's Event!
September 27-30, 2022Boston Convention and Exhibition Center

Our Scientific Advisory Board

Ravi Bhatia, MSc., Scientific Director, PDMS, Janssen R&D

Christopher Bravery, Ph.D., Director, Consulting on Advanced Biologicals Ltd, United Kingdom

David Brindley, DPhil, MEng, FRSA Managing Partner, Biolacuna & Senior Research Fellow, Nuffield Department of Paediatrics, University of Oxford, United Kingdom

Bruce Levine, Ph.D., Barbara and Edward Netter Professor of Cancer Gene Therapy, Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania

John McMannis, Ph.D., Executive Vice President, Manufacturing, Mesoblast

Mahendra Rao, Ph.D., M.D., Vice President, Regenerative Medicine, Q Therapeutic, Strategic Advisor, The New York Stem Cell Foundation

Jon Rowley, Ph.D., Founder & Chief Technology Officer, RoosterBio Inc.

Lior Raviv, Vice President Development, Pluristem, Israel